section-3a67bd4

Research & Development

section-e00d821

Eco Equity has an exclusive genetics pool that has been developed internally by our head of cultivation/genetics over the course of 12 years.

As part of an R&D effort involving selective breeding of the most formidable and adaptive genetics from around the world. We can offer these on an exclusive basis to our partners.

Many strains can be developed with desired compounds in higher or lower concentrations such as terpenes and some of the common or the rarer but highly efficacious cannabinoids (CBD, THC, THCV, CBDP etc.)

//www.eco-equity.com/wp-content/uploads/2020/11/scientist-examining-cannabis-plant.jpeg
section-067357e

Eco Equity works very closely with the Harare Institute for Technology (HIT), a Zimbabwe-based scientific institute dedicated to technopreneurial leadership. The relevant domains of expertise and collaboration include:

  • Essential oils
  • Fixed oils
  • Drug development and formulations from natural sources.

With a focus on non-communicable and chronic diseases, such as cancer, diabetes, hypertension, arthritis, fibroids and endometriosis.

//www.eco-equity.com/wp-content/uploads/2020/11/AdobeStock_260508703-1.jpeg
//www.eco-equity.com/wp-content/uploads/2020/11/HIT-logo-no-bg.png

Acquired licenses to supply the global demand of an effective form of medicinal cannabis to the pharmaceutical industry.

  • 0207 043 1541

  • info@eco-equity.com

  • 120 Moorgate, London, EC2M 6UR

  • Mon-Fri: 9am - 6pm